One Medical Group Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:One Medical Group Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10670
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
One Medical Group Inc (One Medical) is a provider of medical and technology-enabled health care services. The company’s service offerings include primary and pediatric care, prenatal and women’s health, nutrition and sports medicine, LGBT care, mental health, dermatology, family and integrative medicine, onsite labs, travel health and flu-shots. It also offers membership benefits such as same-day appointments, 24/7 virtual care, online appointment scheduling, insurance, and email access to a physician’s. One Medical is affiliated with 1Life Healthcare, Inc. The company has operations with offices in Boston, Chicago, Los Angeles, New York, Phoenix, San Francisco, Seattle, and Washington. One Medical is headquartered in San Francisco, California, the US.

One Medical Group Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
One Medical Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
One Medical Group Inc, Medical Devices Deals, 2012 to YTD 2018 8
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
One Medical Group Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
One Medical Group raises US$40 million from Redmile Group and existing investors 10
One Medical Raises US$40 Million In Venture Financing 11
One Medical Group Raises US$30 Million In Series F Financing 12
One Medical Group Inc – Key Competitors 13
One Medical Group Inc – Key Employees 14
One Medical Group Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 17
Corporate Communications 17
Jul 19, 2017: One Medical Names Amir Dan Rubin as New President and CEO 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
One Medical Group Inc, Pharmaceuticals & Healthcare, Key Facts 2
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
One Medical Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
One Medical Group Inc, Medical Devices Deals, 2012 to YTD 2018 8
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
One Medical Group raises US$40 million from Redmile Group and existing investors 10
One Medical Raises US$40 Million In Venture Financing 11
One Medical Group Raises US$30 Million In Series F Financing 12
One Medical Group Inc, Key Competitors 13
One Medical Group Inc, Key Employees 14
One Medical Group Inc, Other Locations 15
One Medical Group Inc, Subsidiaries 16

List of Figures
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
One Medical Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
One Medical Group Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[One Medical Group Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lung Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Therapeutics Inc (Lung Therapeutics) is a pharmaceutical company that offers orphan drug indications for lung injury and disease. The company provides service to underserved, life-threatening lung condition pursues an innovative treatment. Its pipeline candidates include LTI-01, single …
  • Union Investment Group:企業の戦略・SWOT・財務情報
    Union Investment Group - Strategy, SWOT and Corporate Finance Report Summary Union Investment Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bellco Srl:医療機器:M&Aディール及び事業提携情報
    Summary Bellco Srl (Bellco), a subsidiary of Medtronic plc, is a biotechnology company that offers hemodialysis solutions. The company provides chronic line, acute line and neonatal patient products. Its chronic line products comprise haemodiafiltration therapies and dialysis machines, among others. …
  • Immersion Corp (IMMR):企業の財務・戦略的SWOT分析
    Summary Immersion Corp (Immersion) is a medical technology company that offers haptic technologies. The company offers TouchSense haptic enabling kits and TouchSense software development kits. It also provides Software, integration and design guides; SDKs, certification of actuators and motors; test …
  • Emerald Resources NL (EMR):企業の財務・戦略的SWOT分析
    Summary Emerald Resources NL (Emerald) is an oil and gas company that carries out mineral exploration and development. The company carries out acquisition, exploration, development and produces oil and natural gas, and gold deposits. Its projects include Okavu Gold project, and Magoffin County proje …
  • Cerebrotech Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cerebrotech Medical Systems Inc (Cerebrotech) is a medical device company focused on the development of neurotechnology solutions for non-invasive monitoring of patients after stroke or traumatic brain injury. The company’s Cerebrotech Visor is a portable non-invasive wireless neuro monitori …
  • Sky Metals Ltd (SKY):企業の財務・戦略的SWOT分析
    Summary Sky Metals Ltd (Sky Metals) is an upstream oil and gas company that offers acquisition, exploration, production and development of oil and gas properties in the US. The company holds interests in conventional and unconventional oil and gas projects in Australia. It projects explores for coal …
  • Sinclairs Hotels Limited:企業の戦略・SWOT・財務情報
    Sinclairs Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Sinclairs Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Breeze-Eastern Corporation:企業の戦略・SWOT・財務情報
    Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report Summary Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Nanyang Technological University:企業の戦略的SWOT分析
    Nanyang Technological University - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Conatus Pharmaceuticals Inc (CNAT):企業の財務・戦略的SWOT分析
    Summary Conatus Pharmaceuticals Inc (Conatus) is a biotechnology company that develops and commercializes novel medicines for the treatment of liver diseases. The company’s lead pipeline candidate includes emricasan, an orally active pan-caspase protease inhibitor which is designed to reduce the act …
  • Abbott Diagnostics:企業の製品パイプライン分析2018
    Summary Abbott Diagnostics, a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics portfolio. Its products include labo …
  • Siemens Ltd (SIEMENS):企業の財務・戦略的SWOT分析
    Siemens Ltd (SIEMENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Barilla Holding S.p.A.:企業の戦略・SWOT・財務情報
    Barilla Holding S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Barilla Holding S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Synthon Holdings BV-製薬・医療分野:企業M&A・提携分析
    Summary Synthon Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture and distribution of generics, active pharmaceutical ingredients and biopharmaceutic …
  • Natura Cosmeticos SA:戦略・SWOT・企業財務分析
    Natura Cosmeticos SA - Strategy, SWOT and Corporate Finance Report Summary Natura Cosmeticos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Dongfang Electric Corporation Ltd (1072):企業の財務・戦略的SWOT分析
    Dongfang Electric Corporation Ltd (1072) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • CareDx Inc (CDNA):企業の財務・戦略的SWOT分析
    Summary CareDx Inc (CareDx) formerly XDx Inc, is a molecular diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. The company offers products which include AlloMap, a noninvasive blood test used by clinicians to monitor and …
  • MeVis Medical Solutions AG (M3V)-医療機器分野:企業M&A・提携分析
    Summary MeVis Medical Solutions AG (MMS AG) is a medical technology company. It develops and offers medical imaging solutions for digital computer-aided medical imaging. The software solutions are used in screening, diagnostics, therapy and intervention planning for breast, lung, colon, and prostate …
  • Park Electrochemical Corp (PKE):企業の財務・戦略的SWOT分析
    Summary Park Electrochemical Corp (Park Electrochemical) is a technology company that develops and manufactures high technology digital and radio frequency and microwave printed circuit materials. The company provides advanced composite materials in product forms such as broadgoods, unidirectional t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆